0000950170-24-041843.txt : 20240404 0000950170-24-041843.hdr.sgml : 20240404 20240404163045 ACCESSION NUMBER: 0000950170-24-041843 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240402 FILED AS OF DATE: 20240404 DATE AS OF CHANGE: 20240404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lim Jonathan E CENTRAL INDEX KEY: 0001283290 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41989 FILM NUMBER: 24823524 MAIL ADDRESS: STREET 1: 11588 SORRENTO VALLEY ROAD, SUITE 17 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER NAME: FORMER CONFORMED NAME: LIM JONATHAN E DATE OF NAME CHANGE: 20040310 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Boundless Bio, Inc. CENTRAL INDEX KEY: 0001782303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 830751369 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9880 CAMPUS POINT DRIVE STREET 2: SUITE 120 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 766-9912 MAIL ADDRESS: STREET 1: 9880 CAMPUS POINT DRIVE STREET 2: SUITE 120 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 ownership.xml 4 X0508 4 2024-04-02 0001782303 Boundless Bio, Inc. BOLD 0001283290 Lim Jonathan E C/O BOUNDLESS BIO, INC. 9880 CAMPUS POINT DRIVE, SUITE 120 SAN DIEGO CA 92121 true false false false false Common Stock 2024-04-02 4 C false 525274 A 550915 I By City Hill, LLC Common Stock 102564 D Series A Convertible Preferred Stock 2024-04-02 4 C false 512820 D Common Stock 512820 0 I By City Hill, LLC Series B Convertible Preferred Stock 2024-04-02 4 C false 5128 D Common Stock 5128 0 I By City Hill, LLC Series C Convertible Preferred Stock 2024-04-02 4 C false 7326 D Common Stock 7326 0 I By City Hill, LLC Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering. Consists of shares held directly by City Hill, LLC ("City Hill"). Jonathan E. Lim, M.D. serves as the managing partner of City Hill. Dr. Lim exercises voting and dispositive control over the securities held by City Hill and is therefore deemed to be a beneficial owner of securities owned by City Hill. Dr. Lim disclaims beneficial ownership of the reported securities held by City Hill, except to the extent of his pecuniary interest therein. /s/ Jessica Oien, Attorney-in-Fact for Jonathan Lim 2024-04-04